Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

The metabolic syndrome—a new worldwide definition

Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · see citing works

Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · see citing works

Nonalcoholic Fatty Liver Disease

Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228 · see citing works

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

The importance of the ratio of omega-6/omega-3 essential fatty acids

Simopoulos, A. P. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00253-6 · Cited by 4,166 · see citing works

Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology

Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817 · see citing works

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,805 · see citing works

Mechanisms of fatty acid-induced inhibition of glucose uptake.

Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,702 · see citing works

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Body Fatness and Cancer — Viewpoint of the IARC Working Group

Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596 · see citing works

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · see citing works

TGFβ signalling in context

Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,130 · see citing works

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,067 · see citing works

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932 · see citing works

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903 · see citing works

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890 · see citing works

Mechanisms of Hepatic Fibrogenesis

Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,640 · see citing works

Regulation and Function of NF-κB Transcription Factors in the Immune System

Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,578 · see citing works

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · see citing works

Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis

Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works

Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,413 · see citing works

Origins and evolution of the Western diet: health implications for the 21st century1,2

Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A., O’Keefe, J. H., & Brand-Miller, J. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.341 · Cited by 2,397 · see citing works

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · see citing works

Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference

Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,155 · see citing works

Human Fatty Liver Disease: Old Questions and New Insights

Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · see citing works

Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance

Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · see citing works

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · see citing works

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,773 · see citing works

Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance

Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717 · see citing works

The global NAFLD epidemic

Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,696 · see citing works

Targeting the TGFβ signalling pathway in disease

Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · see citing works

A lipidomic analysis of nonalcoholic fatty liver disease

Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · see citing works

The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling

Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,322 · see citing works

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169 · see citing works

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · see citing works

Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease

Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · see citing works

Correction: Corrigendum: Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization

Gao, H., Yang, Z. H., Zhang, S., Cao, S., Shen, S.-Q., Pang, Z., & Jiang, X. (2014) · Scientific Reports · doi:10.1038/srep05138 · Cited by 1,062 · see citing works

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.Preprint

Kim, J. B., & Spiegelman, B. M. (1996) · Genes & Development · doi:10.1101/gad.10.9.1096 · Cited by 1,026 · see citing works

Epidemiology of Non-Alcoholic Fatty Liver Disease

Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · see citing works

Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis

Brasaemle, D. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700014-jlr200 · Cited by 997 · see citing works

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

Yokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/s0092-8674(05)80095-9 · Cited by 968 · see citing works

Metabolism of highly unsaturated n-3 and n-6 fatty acids

Sprecher, H. W. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00077-9 · Cited by 869 · see citing works

Non‐alcoholic fatty liver disease

Angulo, P., & Lindor, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 838 · see citing works

Hepatocellular carcinoma

Forner, A., Llovet, J., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 833 · see citing works

A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation.

Erridge, C., Attina, T., Spickett, C. M., & Webb, D. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1286 · Cited by 776 · see citing works

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771 · see citing works

Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up

Söderberg, C., Stal, P. I., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. W. (2009) · Hepatology · doi:10.1002/hep.23314 · Cited by 748 · see citing works

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 12× · see citing works

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661 · see citing works

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

Min, H., Kapoor, A., Fuchs, M. A., Mirshahi, F., Zhou, H., Maher, J. W., Kellum, J. M., Warnick, R., Contos, M. J., & Sanyal, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.004 · Cited by 653 · see citing works

Lipolysis – A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores

Lass, A., Zimmermann, R., Oberer, M., & Zechner, R. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.10.004 · Cited by 641 · see citing works

The Biochemistry of n-3 Polyunsaturated Fatty Acids

Jump, D. Β. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100062200 · Cited by 638 · see citing works

SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element.

Hua, X., Yokoyama, C., Wu, J. I., Briggs, M. R., Brown, M. S., Goldstein, J. L., & Wang, X. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11603 · Cited by 626 · see citing works

Evolving therapies for liver fibrosis

Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 596 · see citing works

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.128 · Cited by 592 · see citing works

Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy

Thornalley, P. J. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02054-3 · Cited by 591 · see citing works

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

McCullough, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.004 · Cited by 578 · see citing works

Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis

Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569 · see citing works

A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease

Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 561 · see citing works

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Takahashi, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2300 · Cited by 554 · see citing works

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Asgharpour, A., Cazanave, S. C., Pacana, T., Seneshaw, M., Vincent, R., Banini, B. A., Kumar, D. P., Daita, K., Min, H.-K., Mirshahi, F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.005 · Cited by 538 · see citing works

Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis

Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 531 · see citing works

Hepatocellular carcinoma epidemiology

Bosetti, C., Turati, F., & Vecchia, C. L. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.007 · Cited by 531 · see citing works

World Gastroenterology Organisation Global Guidelines

LaBrecque, D. R., Abbas, Z., Anania, F. A., Ferenci, P., Khan, A. G., Goh, K., Hamid, S. S., Va, I., Lizarzábal, M., Peñaranda, M. M., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000116 · Cited by 520 · see citing works

The Etiology of Hepatocellular Carcinoma and Consequences for Treatment

Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-14 · Cited by 517 · see citing works

Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome

Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492 · see citing works

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†

Wouters, K., van Gorp, P. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lütjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., et al. (2008) · Hepatology · doi:10.1002/hep.22363 · Cited by 477 · see citing works

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis

Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9607 · Cited by 449 · see citing works

Innate immunity in diabetes and diabetic nephropathy

Wada, J., & Makino, H. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 432 · see citing works

Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study

Capanni, M., Calella, F., Biagini, M. R., Genise, S., Raimondi, L., Bedogni, G., Svegliati‐Baroni, G., Sofi, F., Milani, S., Abbate, R., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02885.x · Cited by 405 · see citing works

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal

Alkhouri, N., Dixon, L. J., & Feldstein, A. E. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.32 · Cited by 400 · see citing works

Elevated endotoxin levels in non-alcoholic fatty liver disease

Harte, A. L., da Silva, N. F., Creely, S. J., McGee, K. C., Billyard, T., Elabd, E. M. Y., Tripathi, G., Ashour, E., Abdalla, M. S., Sharada, H. M., et al. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-15 · Cited by 390 · see citing works

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379 · see citing works

ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver

Ma, L., Robinson, L. N., & Towle, H. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601576200 · Cited by 373 · see citing works

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

Bays, H. E., Ballantyne, C. M., Kastelein, J. J., Isaacsohn, J. L., Braeckman, R. A., & Soni, P. N. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.04.015 · Cited by 358 · see citing works

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355 · see citing works

Mediterranean diet and nonalcoholic fatty liver disease

Anania, C., Perla, F. M., Olivero, F., Pacifico, L., & Chiesa, C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2083 · Cited by 353 · see citing works

Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids

Arendt, B. M., Comelli, E. M., David, W. L., Lou, W. Y. W., Teterina, A. A., Kim, T., Fung, S. K., Wong, D., McGilvray, I. D., Fischer, S. E., et al. (2015) · Hepatology · doi:10.1002/hep.27695 · Cited by 335 · see citing works

Isoprostane Generation and Function

Milne, G. L., Yin, H., Hardy, K. D., Davies, S. S., & Roberts, L. J. (2011) · Chemical Reviews · doi:10.1021/cr200160h · Cited by 331 · see citing works

Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity

Wang, Y., Botolin, D., Xu, J., Christian, B., Mitchell, E., Bolleddula, J., Nair, M. G., Peters, J. M., Busik, J. V., Olson, L. K., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600177-jlr200 · Cited by 326 · see citing works

Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies

Sunny, N. E., Bril, F., & Cusi, K. J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.006 · Cited by 321 · see citing works

Pathophysiology of nonalcoholic steatohepatitis.

McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 317 · see citing works

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Scorletti, E., Bhatia, L. S., McCormick, K. G., Clough, G. F., Nash, K. L., Hodson, L., Moyses, H. E., Calder, P. C., Byrne, C. D., Sheron, N., et al. (2014) · Hepatology · doi:10.1002/hep.27289 · Cited by 310 · see citing works

No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial

Sanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O. W., & Chojkier, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.046 · Cited by 309 · see citing works

Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids.

Jump, D. Β., Clarke, S. D., Thelen, A. P., & Liimatta, M. B. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40103-8 · Cited by 305 · see citing works

Pathophysiology of Nonalcoholic Steatohepatitis

Başaranoğlu, M. (2009) · Cited by 294 · see citing works

Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease

Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C. E., Alagona, C., Papa, G. F. S., Rabuazzo, A. M., & Purrello, F. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.003 · Cited by 293 · see citing works

Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation

Laugerette, F., Vors, C., Géloën, A., Chauvin, M., Soulage, C. O., Lambert-Porcheron, S., Peretti, N., Alligier, M., Burcelin, R., Laville, M., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.011 · Cited by 291 · see citing works

Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective

Jialal, I., Kaur, H., & Devaraj, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3092 · Cited by 286 · see citing works

Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

Wei, M. Y., & Jacobson, T. A. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0210-3 · Cited by 284 · see citing works

Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase

Owen, J., Zhang, Y., Bae, S., Farooqi, M., Liang, G., Hammer, R., Goldstein, J., & Brown, M. S. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1213343109 · Cited by 276 · see citing works

Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases

Wang, Y., Botolin, D., Christian, B., Busik, J. V., Xu, J., & Jump, D. Β. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400335-jlr200 · Cited by 265 · see citing works

Polyunsaturated Fatty Acid Suppression of Hepatic Fatty Acid Synthase and S14 Gene Expression Does Not Require Peroxisome Proliferator-activated Receptor α

Ren, B., Thelen, A. P., Peters, J. M., Gonzalez, F. J., & Jump, D. Β. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26827 · Cited by 264 · see citing works

Pathophysiology of Nonalcoholic Steatohepatitis

Watanabe, S. (2017) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.63.230 · Cited by 257 · see citing works

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

Nobili, V., Bedogni, G., Alisi, A., Pietrobattista, A., Risé, P., Galli, C., & Agostoni, C. V. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.192401 · Cited by 255 · see citing works

Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis , , ,

Chung, M. C., Ma, J., Patel, K., Berger, S. E., Lau, J. S. M., & Lichtenstein, A. H. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086314 · Cited by 253 · see citing works

A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study

Allaire, J., Couture, P., Leclerc, M., Charest, A., Marin, J., Lépine, M.-C., Talbot, D., Tchernof, A., & Lamarche, B. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.131896 · Cited by 252 · see citing works

The differential effects of EPA and DHA on cardiovascular risk factors

Cottin, S. C., Sanders, T. A., & Hall, W. L. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000061 · Cited by 247 · see citing works

Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study

Allard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247 · see citing works

Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup

Stanhope, K. L., & Havel, P. J. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.25825d · Cited by 237 · see citing works

Non-alcoholic fatty liver disease and risk of cardiovascular disease

Lonardo, A., Sookoian, S. C., Pirola, C. J., & Targher, G. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236 · see citing works

Fatty Acid–Regulated Transcription Factors in the Liver

Jump, D. Β., Tripathy, S., & Depner, C. M. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161139 · Cited by 228 · see citing works

Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins

Smagris, E., Gilyard, S., BasuRay, S., Cohen, J. C., & Hobbs, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719955 · Cited by 226 · see citing works

Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases

Gugliucci, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013912 · Cited by 225 · see citing works

Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial

Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224 · see citing works

Mlx Is the Functional Heteromeric Partner of the Carbohydrate Response Element-binding Protein in Glucose Regulation of Lipogenic Enzyme Genes

Stoeckman, A. K., Ma, L., & Towle, H. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311301200 · Cited by 218 · see citing works

Relationships between plasma fatty acid composition and coronary artery disease.

Itakura, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Kita, T., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5876 · Cited by 218 · see citing works

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3977-1 · Cited by 218 · see citing works

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Prashanth, M., Ganesh, H. K., Vima, M. V., John, M., Bandgar, T., Joshi, S., Shah, S., Rathi, P. M., Joshi, A. S., Thakkar, H. U., et al. (2009) · PubMed · Cited by 217 · see citing works

Behavioural treatment strategies improve adherence to lifestyle intervention programmes in adults with obesity: A systematic review and meta-analysis

Burgess, E., Hassmén, P., Welvaert, M., & Pumpa, K. L. (2017) · Clinical Obesity · doi:10.1111/cob.12180 · Cited by 214 · see citing works

Novel insights into ChREBP regulation and function

Filhoulaud, G., Guilmeau, S., Dentin, R., Girard, J. R., & Postic, C. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.01.003 · Cited by 211 · see citing works

Human Biochemistry of the Isoprostane Pathway

Milne, G. L., Yin, H., & Morrow, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700047200 · Cited by 209 · see citing works

Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage

Uyeda, K., Yamashita, H., & Kawaguchi, T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01012-2 · Cited by 206 · see citing works

Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials

Sato, K., Gosho, M., Yamamoto, T., Kobayashi, Y., Ishii, N., Ohashi, T., Nakade, Y., Ito, K., Fukuzawa, Y., & Yoneda, M. (2014) · Nutrition · doi:10.1016/j.nut.2014.11.018 · Cited by 200 · see citing works

Unsaturated Fatty Acid Regulation of Peroxisome Proliferator-activated Receptor α Activity in Rat Primary Hepatoctes

Pawar, A., & Jump, D. Β. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306238200 · Cited by 197 · see citing works

Sterol Response Element-binding Protein 1c (SREBP1c) Is Involved in the Polyunsaturated Fatty Acid Suppression of Hepatic S14 Gene Transcription

Mater, M. K., Thelen, A. P., Pan, D. A., & Jump, D. Β. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32725 · Cited by 194 · see citing works

Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats

Pagliassotti, M. J., Prach, P. A., Koppenhafer, T. A., & Pan, D. A. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.5.r1319 · Cited by 186 · see citing works

Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia

Zhu, F., Liu, S., Chen, X.-M., Huang, Z., & Zhang, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6395 · Cited by 186 · see citing works

Fatty acid synthesis during early linoleic acid deficiency in the mouse

Allmann, D. W., & Gibson, D. M. (1965) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39639-5 · Cited by 184 · see citing works

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

Cussons, A. J., Watts, G. F., Mori, T. A., & Stuckey, B. G. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0870 · Cited by 181 · see citing works

Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis

Glass, L. M., Dickson, R. C., Anderson, J. C., Suriawinata, A. A., Putra, J., Berk, B. S., & Toor, A. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3380-3 · Cited by 178 · see citing works

LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease

Bieghs, V., van Gorp, P. J., Wouters, K., Hendrikx, T., Gijbels, M. J., van Bilsen, M., Bakker, J. A., Binder, C. J., Lütjohann, D., Staels, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030668 · Cited by 175 · see citing works

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease

Minno, M. N. D. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5839 · Cited by 173 · see citing works

Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study

Zhang, J., Zhao, Y. Y., Xu, C., Hong, Y., Lu, H., Wu, J., & Chen, Y. (2014) · Scientific Reports · doi:10.1038/srep05832 · Cited by 172 · see citing works

Strategies for anti-fibrotic therapies

Rosenbloom, J., Mendoza, F. A., & Jiménez, S. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 171 · see citing works

Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis

Itoh, M., Suganami, T., Nakagawa, N., Tanaka, M., Yamamoto, Y., Kamei, Y., Terai, S., Sakaida, I., & Ogawa, Y. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.014 · Cited by 167 · see citing works

Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis

Lee, J. J., Lambert, J. E., Hovhannisyan, Y., Ramos-Román, M. A., Trombold, J. R., Wagner, D. A., & Parks, E. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092262 · Cited by 165 · see citing works

Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways

Botolin, D., Wang, Y., Christian, B., & Jump, D. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500365-jlr200 · Cited by 162 · see citing works

Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta‐analysis

Singh, S., Khera, R., Allen, A. M., Murad, M. H., & Loomba, R. S. (2015) · Hepatology · doi:10.1002/hep.27999 · Cited by 162 · see citing works

Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis

Dasarathy, S., Dasarathy, J., Khiyami, A., Yerian, L. M., Hawkins, C., Sargent, R., & McCullough, A. J. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000099 · Cited by 161 · see citing works

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

Park, B. J., Kim, Y. J., Kim, D., Kim, W. K., Jung, Y. J., Yoon, J., Kim, C. Y., Cho, Y. M., Kim, S. H., Lee, K. B., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05212.x · Cited by 154 · see citing works

Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids.

Lee, J. Y., Zhao, L., & Hwang, D. (2010) · Nutrition reviews · doi:10.1111/j.1753-4887.2009.00259.x · Cited by 153 · see citing works

HEP computing : where are we now? - open questions for the CHEP'91 conference

Thresher, J. J. (1992) · CERN Document Server (European Organization for Nuclear Research) · Cited by 150 · see citing works

Glucose as a regulator of eukaryotic gene transcription

Towle, H. C. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.10.003 · Cited by 149 · see citing works

Epidemiology of the metabolic syndrome in the USA

McCullough, A. J. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00469.x · Cited by 146 · see citing works

Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis

Depner, C. M., Philbrick, K. A., & Jump, D. Β. (2013) · Journal of Nutrition · doi:10.3945/jn.112.171322 · Cited by 145 · see citing works

Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children

Nobili, V., Alisi, A., Corte, C. D., Risé, P., Galli, C., Agostoni, C. V., & Bedogni, G. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.10.010 · Cited by 144 · see citing works

Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes.

Jump, D. Β., Clarke, S. D., MacDougald, O. A., & Thelen, A. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8454 · Cited by 142 · see citing works

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease

Boursier, J., & Diehl, A. M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004559 · Cited by 134 · see citing works

Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries

Yoshida, K., & Matsuzaki, K. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00053 · Cited by 131 · see citing works

Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

He, X., Wu, X., Chen, R., Chen, C., Liu, X., Wu, B.-J., & Huang, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162368 · Cited by 129 · see citing works

Transcriptional Control of the Stearoyl-CoA Desaturase-1 Gene by Polyunsaturated Fatty Acids1

Landschulz, K., Jump, D. Β., MacDougald, O. A., & Lane, M. D. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1516 · Cited by 128 · see citing works

Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

Jańczyk, W., Lebensztejn, D. M., Wierzbicka, A., Mazur, A., Neuhoff-Murawska, J., Matusik, P., & Socha, P. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.01.056 · Cited by 126 · see citing works

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis

Lu, W., Li, S., Li, J., Wang, J., Zhang, R., Zhou, Y., Yin, Q., Zheng, Y., Wang, F., Xia, Y., et al. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/1459790 · Cited by 124 · see citing works

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

Nogueira, M. A., de Oliveira, C. P. M. S., Alves, V. A. F., Stefano, J. T., Rodrigues, L., Torrinhas, R. S., Cogliati, B., Barbeiro, H. V., Carrilho, F. J., & Waitzberg, D. L. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.05.001 · Cited by 123 · see citing works

Nonalcoholic fatty liver disease and cardiovascular risk

Misra, V. L., Khashab, M. A., & Chalasani, N. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0008-4 · Cited by 122 · see citing works

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease

Nobili, V., Carpino, G., Alisi, A., Vito, R. D., Franchitto, A., Alpini, G. D., Onori, P., & Gaudio, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088005 · Cited by 120 · see citing works

Plasma incorporation, apparent retroconversion and β-oxidation of 13C-docosahexaenoic acid in the elderly

Plourde, M., Chouinard‐Watkins, R., Vandal, M., Zhang, Y., Lawrence, P., Brenna, J. T., & Cunnane, S. C. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-5 · Cited by 111 · see citing works

Gut microbiota and liver disease

Goel, A., Gupta, M. C., & Aggarwal, R. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12556 · Cited by 111 · see citing works

Dietary polyunsaturated fatty acids interfere with the insulin/glucose activation of L-type pyruvate kinase gene transcription

Liimatta, M. B., Towle, H. C., Clarke, S. D., & Jump, D. Β. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.9.7838147 · Cited by 108 · see citing works

Regulation of Nuclear Import/Export of Carbohydrate Response Element-binding Protein (ChREBP)

Sakiyama, H., Wynn, R., Lee, W.-R., Fukasawa, M., Mizuguchi, H., Gardner, K. H., Repa, J. J., & Uyeda, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804308200 · Cited by 106 · see citing works

A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease

Pacifico, L., Bonci, E., Martino, M. D., Versacci, P., Andreoli, G., Silvestri, L. M., & Chiesa, C. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.04.003 · Cited by 103 · see citing works

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial

Qin, Y., Zhou, Y. G., Chen, S., Zhao, X.-L., Ran, L., Zeng, X.-L., Wu, Y., Chen, J., Kang, C., Shu, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133496 · Cited by 101 · see citing works

Glucose Activates ChREBP by Increasing Its Rate of Nuclear Entry and Relieving Repression of Its Transcriptional Activity

Davies, M. N., O’Callaghan, B. L., & Towle, H. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801539200 · Cited by 94 · see citing works

The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease

Schuck, R. N., Zha, W., Edin, M. L., Gruzdev, A., Vendrov, K. C., Miller, T. M., Xu, Z., Lih, F. B., DeGraff, L. M., Tomer, K. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110162 · Cited by 92 · see citing works

Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice

Ishii, H., Horie, Y., Ohshima, S., Anezaki, Y., Kinoshita, N., Dohmen, T., Kataoka, E., Sato, W., Goto, T., Sasaki, J., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.031 · Cited by 90 · see citing works

Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis

Pickens, M., Yan, J. S., Ng, R., Ogata, H., Grenert, J. P., Beysen, C., Turner, S., & Maher, J. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900022-jlr200 · Cited by 90 · see citing works

The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling

Nyati, S., Schinske, K. A., Pitchiaya, S., Chekhovskiy, K., Chator, A., Chaudhry, N., Dosch, J. S., Dort, M. E. V., Varambally, S., Kumar‐Sinha, C., et al. (2015) · Science Signaling · doi:10.1126/scisignal.2005379 · Cited by 90 · see citing works

Mediterranean diet and non-alcoholic fatty liver disease: New therapeutic option around the corner?

Sofi, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7339 · Cited by 88 · see citing works

Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.

Wang, X., Li, W., Zhang, Y., Yang, Y., & Qin, G. (2015) · PubMed Central · Cited by 88 · see citing works

Fatty Acid Regulation of Liver X Receptors (LXR) and Peroxisome Proliferator-activated Receptor α (PPARα) in HEK293 Cells

Pawar, A., Xu, J., Jerks, E., Mangelsdorf, D. J., & Jump, D. Β. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206170200 · Cited by 80 · see citing works

Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis

Li, Y.-H., Yang, L., Sha, K., Liu, T., Zhang, L., & Liu, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i22.7008 · Cited by 80 · see citing works

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

Leung, C., Herath, C. B., Jia, Z., Andrikopoulos, S., Brown, B. E., Davies, M. J., Rivera, L. R., Furness, J. B., Forbes, J. M., & Angus, P. W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i35.8026 · Cited by 80 · see citing works

Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease

Boyraz, M., Pirgon, Ö., Dündar, B. N., Çekmez, F., & Hatipoğlu, N. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1749 · Cited by 78 · see citing works

Regulation of Rat Hepatic L-Pyruvate Kinase Promoter Composition and Activity by Glucose, n-3 Polyunsaturated Fatty Acids, and Peroxisome Proliferator-activated Receptor-α Agonist

Xu, J., Christian, B., & Jump, D. Β. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601277200 · Cited by 76 · see citing works

How should we manage patients with non‐alcoholic fatty liver disease in 2007?

Chan, H. L., de Silva, H. J., Leung, N. W. Y., Lim, S. G., Farrell, G. C., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04977.x · Cited by 74 · see citing works

Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial

Asztalos, I. B., Gleason, J. A., Sever, S., Gedik, R., Asztalos, B. F., Horvath, K. V., Dansinger, M. L., Lamon‐Fava, S., & Schaefer, E. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.010 · Cited by 74 · see citing works

Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia

Barter, P. J., & Ginsberg, H. N. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.056 · Cited by 72 · see citing works

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice

Suzuki‐Kemuriyama, N., Matsuzaka, T., Kuba, M., Ohno, H., Han, S., Takeuchi, Y., Isaka, M., Kobayashi, K., IWASAKI, H. O., Yatoh, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157580 · Cited by 68 · see citing works

Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese BL/6J mice

Tripathy, S., Torres‐Gonzalez, M., & Jump, D. Β. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006080 · Cited by 67 · see citing works

n-3 Fatty Acid-Derived Lipid Mediators in the Brain: New Weapons Against Oxidative Stress and Inflammation

Farooqui, A. A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712798918851 · Cited by 65 · see citing works

Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice

Lytle, K. A., Wong, C. P., & Jump, D. Β. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173376 · Cited by 62 · see citing works

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD)

Sawangjit, R., Chongmelaxme, B., Phisalprapa, P., Saokaew, S., Thakkinstian, A., Kowdley, K. V., & Chaiyakunapruk, N. (2016) · Medicine · doi:10.1097/md.0000000000004529 · Cited by 61 · see citing works

Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice

Tripathy, S., Lytle, K. A., Stevens, R. D., Bain, J. R., Newgard, C. B., Greenberg, A. S., Huang, L., & Jump, D. Β. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050062 · Cited by 60 · see citing works

A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR-/- Mice

Depner, C. M., Traber, M. G., Bobe, G., Kensicki, E., Bohren, K. M., Milne, G. L., & Jump, D. Β. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083756 · Cited by 58 · see citing works

Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain

Kerr, T. A., Davidson, N. O., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26088 · Cited by 55 · see citing works

Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism

Baraille, F., Planchais, J., Dentin, R., Guilmeau, S., & Postic, C. (2015) · Physiology · doi:10.1152/physiol.00016.2015 · Cited by 55 · see citing works

Thiazolidinediones for nonalcoholic steatohepatitis

He, L., Liu, X., Wang, L., & Yang, Z. (2016) · Medicine · doi:10.1097/md.0000000000004947 · Cited by 55 · see citing works

Isoprostanes and 4-Hydroxy-2-nonenal: Markers or Mediators of Disease? Focus on Rett Syndrome as a Model of Autism Spectrum Disorder

Signorini, C., Felice, C. D., Durand, T., Oger, C., Galano, J., Leoncini, S., Pecorelli, A., Valacchi, G., Ciccoli, L., & Hayek, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/343824 · Cited by 53 · see citing works

Isoprostanes and Related Compounds: Update 2006

Milne, G. L., & Morrow, J. D. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1379 · Cited by 51 · see citing works

Current and future pharmacologic treatment of nonalcoholic steatohepatitis

Banini, B. A., & Sanyal, A. J. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000356 · Cited by 50 · see citing works

Resistant starch and exercise independently attenuate weight regain on a high fat diet in a rat model of obesity

HIGGINS, J. A., Jackman, M. R., Brown, I. L., Johnson, G. C., Steig, A. J., Wyatt, H. R., Hill, J. O., & MacLean, P. S. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-49 · Cited by 47 · see citing works

Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr mice by targeting the TGFβ-Smad3 pathway

Lytle, K. A., Depner, C. M., Wong, C. P., & Jump, D. B. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m061275 · Cited by 45 · see citing works

Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice

Vasandani, C., Kafrouni, A. I., Caronna, A., Bashmakov, Y. K., Gotthardt, M., Horton, J. D., & Spady, D. K. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30120-6 · Cited by 44 · see citing works

Ces3/TGH Deficiency Attenuates Steatohepatitis

Lian, J., Wei, E., Groenendyk, J., Das, S. K., Hermansson, M., Li, L., Watts, R., Thiesen, A., Oudit, G. Y., Michalak, M., et al. (2016) · Scientific Reports · doi:10.1038/srep25747 · Cited by 44 · see citing works

Eicosapentaenoic Acid Ameliorates Non-Alcoholic Steatohepatitis in a Novel Mouse Model Using Melanocortin 4 Receptor-Deficient Mice

Konuma, K., Itoh, M., Suganami, T., Kanai, S., Nakagawa, N., Sakai, T., Kawano, H., Hara, M., Kojima, S., Izumi, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121528 · Cited by 43 · see citing works

Menhaden Oil Decreases High-Fat Diet–Induced Markers of Hepatic Damage, Steatosis, Inflammation, and Fibrosis in Obese Ldlr−/− Mice

Depner, C. M., Torres‐Gonzalez, M., Tripathy, S., Milne, G. L., & Jump, D. Β. (2012) · Journal of Nutrition · doi:10.3945/jn.112.158865 · Cited by 43 · see citing works

Metabolic fate of docosahexaenoic acid ( DHA ; 22:6n‐3) in human cells: direct retroconversion of DHA to eicosapentaenoic acid (20:5n‐3) dominates over elongation to tetracosahexaenoic acid (24:6n‐3)

Park, H. G., Lawrence, P., Engel, M. G., Kothapalli, K. S. D., & Brenna, J. T. (2016) · FEBS Letters · doi:10.1002/1873-3468.12368 · Cited by 42 · see citing works

Role of serum toll‐like receptors 2 and 4 in non‐alcoholic steatohepatitis and liver fibrosis

Cengiz, M., Özeni̇rler, S., & Elbeğ, Ş. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12924 · Cited by 41 · see citing works

Selective Proteolytic Processing of Rat Hepatic Sterol Regulatory Element Binding Protein-1 (SREBP-1) and SREBP–2 During Postnatal Development

Botolin, D., & Jump, D. Β. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212846200 · Cited by 41 · see citing works

Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?

Lytle, K. A., & Jump, D. Β. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146942 · Cited by 41 · see citing works

Management of non-alcoholic fatty liver disease in 2015

Malhotra, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i30.2962 · Cited by 41 · see citing works

Dietary approach in the treatment of nonalcoholic fatty liver disease

Ferolla, S. M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i24.2522 · Cited by 38 · see citing works

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes

Petit, J. M., Guiu, B., Duvillard, L., Jooste, V., Brindisi, M., Athias, A., Bouillet, B., Habchi, M., Cottet, V., Gambert, P., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.007 · Cited by 38 · see citing works

New therapies for hepatic fibrosis

Koyama, Y., & Brenner, D. A. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.06.011 · Cited by 37 · see citing works

Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice

Jump, D. Β., Depner, C. M., Tripathy, S., & Lytle, K. A. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s002966511500244x · Cited by 36 · see citing works

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation

Yang, J., Fernández‐Galilea, M., Martínez‐Fernández, L., González‐Muniesa, P., Pérez-Chávez, A., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Nutrients · doi:10.3390/nu11040872 · Cited by 294 · see citing works

Dietary carbohydrates and fats in nonalcoholic fatty liver disease

Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294 · see citing works

Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action

Scorletti, E., & Byrne, C. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.03.001 · Cited by 161 · see citing works

n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review

Wang, M., Ma, L.-J., Yang, Y., Xiao, Z., & Wan, J.-B. (2019) · Critical reviews in food science and nutrition · doi:10.1080/10408398.2018.1544542 · Cited by 149 · see citing works

Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers—An Overview

Santos, H. O., Price, J. C., & Bueno, A. A. (2020) · Nutrients · doi:10.3390/nu12103159 · Cited by 157 · see citing works

Epigenetics in NAFLD/NASH: Targets and therapy

Sodum, N., Kumar, G., Bojja, S. L., Kumar, N., & Rao, C. M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105484 · Cited by 145 · see citing works

Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study

Kobyliak, N. M., Abenavoli, L., Falalyeyeva, T. M., Mykhalchyshyn, G., Boccuto, L., Kononenko, L., Kyriienko, D., Komisarenko, I., & Dynnyk, O. (2018) · Minerva Medica · doi:10.23736/s0026-4806.18.05845-7 · Cited by 109 · see citing works

Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver

Duwaerts, C. C., & Maher, J. J. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.001 · Cited by 109 · see citing works

The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications

Palma, R., Pronio, A., Romeo, M., Scognamiglio, F., Ventriglia, L., Ormando, V. M., Lamazza, A., Pontone, S., Federico, A., & Dallio, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133649 · Cited by 111 · see citing works

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis

Tang, Y., Huang, J., Zhang, W. Y., Qin, S., Yang, Y. X., Ren, H., Yang, Q.-B., & Hu, H. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819878046 · Cited by 85 · see citing works

New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids

Gorjão, R., Momesso, C. M., Serdan, T. D. A., Diniz, V. L. S., Alba‐Loureiro, T. C., Cury‐Boaventura, M. F., Hatanaka, E., Levada‐Pires, A. C., Sato, F. T., Pithon‐Curi, T. C., et al. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.12.001 · Cited by 84 · see citing works

Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD

Smid, V., Dvořák, K., Šedivý, P., Kosek, V., Martin Lenicek, A., Dezortová, M., Hajšlová, J., Hájek, M., Vı́tek, L., Bechyňská, K., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1906 · Cited by 77 · see citing works

Punicic acid ameliorates obesity and liver steatosis by regulating gut microbiota composition in mice

Yuan, G., Tan, M., & Chen, X. (2021) · Food & Function · doi:10.1039/d1fo01152a · Cited by 76 · see citing works

Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease

Valenzuela, R., Ortíz, M., Hernández‐Rodas, M. C., Echeverría, F., & Videla, L. A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190410121716 · Cited by 75 · see citing works

Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children

Spooner, M. H., & Jump, D. Β. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000539 · Cited by 64 · see citing works

Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies

Zhang, C., Zhou, B.-G., Sheng, J., Chen, Y., Cao, Y.-Q., & Chen, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104984 · Cited by 62 · see citing works

Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use

Spooner, M. H., & Jump, D. Β. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030223 · Cited by 60 · see citing works

Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions

Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04627-0 · Cited by 61 · see citing works

Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms

Mandala, A., Janssen, R., Palle, S. K., Short, K., & Friedman, J. (2020) · Nutrients · doi:10.3390/nu12103166 · Cited by 51 · see citing works

Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: An Updated Comprehensive Practical Guideline

Tabesh, M. R., Eghtesadi, M., Abolhasani, M., Maleklou, F., Ejtehadi, F., & Alizadeh, Z. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06703-2 · Cited by 59 · see citing works

The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis

Méndez-Sánchez, N., Valencia-Rodríguez, A., Coronel-Castillo, C., Vera-Barajas, A., Contreras-Carmona, J., Ponciano-Rodríguez, G., & Zamora-Valdés, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.184 · Cited by 55 · see citing works

An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease

Figueiredo, P. S., Inada, A. C., Fernandes, M. R., Arakaki, D. G., Freitas, K. D. C., Guimarães, R. D. C. A., do Nascimento, V. A., & Hiane, P. A. (2018) · Molecules · doi:10.3390/molecules23040877 · Cited by 48 · see citing works

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease

Lombardi, R., Iuculano, F., Pallini, G., Fargion, S. R., & Fracanzani, A. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228761 · Cited by 44 · see citing works

Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia and steatohepatitis in rats

Fernández‐Martínez, E., Lira‐Islas, I. G., Cariño‐Cortés, R., Soria-Jasso, L. E., Pérez‐Hernández, E., & Pérez‐Hernández, N. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.12986 · Cited by 45 · see citing works

Theaflavin TF3 Relieves Hepatocyte Lipid Deposition through Activating an AMPK Signaling Pathway by targeting Plasma Kallikrein

Zhang, W., An, R., Li, Q., Sun, L., Lai, X., Chen, R., Li, D., & Sun, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00148 · Cited by 45 · see citing works

Four Weeks of Preoperative Omega-3 Fatty Acids Reduce Liver Volume: a Randomised Controlled Trial

Bakker, N., van den Helder, R. S., Geenen, R. W. F., Hunfeld, M. A. J. M., Cense, H. A., Demirkıran, A., & Houdijk, A. P. J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03814-7 · Cited by 40 · see citing works

Effect of Mediterranean diet on liver enzymes: a systematic review and meta-analysis of randomised controlled trials

Sangouni, A. A., Zadeh, S. H., Mozaffari–Khosravi, H., & Hosseinzadeh, M. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002270 · Cited by 40 · see citing works

The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review

Itsiopoulos, C., Marx, W., Mayr, H. L., Tatucu-Babet, O. A., Dash, S. R., George, E. S., Trakman, G. L., Kelly, J. T., Thomas, C. J., & Brazionis, L. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.02.002 · Cited by 37 · see citing works

Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives

Dallio, M., Romeo, M., Gravina, A. G., Masarone, M., Larussa, T., Abenavoli, L., Persico, M., Loguercio, C., & Federico, A. (2021) · Nutrients · doi:10.3390/nu13051679 · Cited by 32 · see citing works

n-3 PUFA Promotes Ferroptosis in PCOS GCs by Inhibiting YAP1 through Activation of the Hippo Pathway

Zhang, P., Pan, Y., Wu, S., He, Y., Wang, J., Chen, L., Zhang, S., Zhang, H., Zhao, Y., Niu, L., et al. (2023) · Nutrients · doi:10.3390/nu15081927 · Cited by 31 · see citing works

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies

Cespiati, A., Meroni, M., Lombardi, R., Oberti, G., Dongiovanni, P., & Fracanzani, A. L. (2022) · Biomedicines · doi:10.3390/biomedicines10010182 · Cited by 30 · see citing works

A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice

García‐Jaramillo, M., Lytle, K. A., Spooner, M. H., & Jump, D. Β. (2019) · Metabolites · doi:10.3390/metabo9110252 · Cited by 30 · see citing works

Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet‐Induced Accumulation of Lipid in the Liver of ApoE−/− Mice

Liu, L., Hu, Q., Wu, H., Wang, X., Gao, C., Chen, G., Yao, P., & Gong, Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6256802 · Cited by 29 · see citing works

Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?

Ogłuszka, M., Lipiński, P., & Starzyński, R. R. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1862047 · Cited by 27 · see citing works

Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus

Pedersen, K. B., Pulliam, C. F., Patel, A., Piero, F. D., Watanabe, T. T. N., Wankhade, U. D., Shankar, K., Hicks, C., & Ronis, M. J. J. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy141 · Cited by 28 · see citing works

Possible Health Effects of a Wax Ester Rich Marine Oil

Schots, P. C., Pedersen, A. M., Eilertsen, K., Olsen, R. L., & Larsen, T. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00961 · Cited by 28 · see citing works

rs953413 Regulates Polyunsaturated Fatty Acid Metabolism by Modulating ELOVL2 Expression

Pan, G., Cavalli, M., Carlsson, B., Skrtic, S., Kumar, C., & Wadelius, C. (2020) · iScience · doi:10.1016/j.isci.2019.100808 · Cited by 26 · see citing works

Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression

Vouilloz, A., Bourgeois, T., Diedisheim, M., Pilot, T., Jalil, A., Guern, N. L., Bergas, V., Rohmer, N., Castelli, F. A., Leleu, D., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156051 · Cited by 26 · see citing works

New Insights into Prospective Health Potential of ω-3 PUFAs

Lakshimi, V. I., & Kavitha, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00508-6 · Cited by 25 · see citing works

Membrane modulatory effects of omega-3 fatty acids: Analysis of molecular level interactions

Ayee, M. A. A., Bunker, B. C., & Groot, J. L. D. (2020) · Current topics in membranes · doi:10.1016/bs.ctm.2020.08.001 · Cited by 24 · see citing works

Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives

Mitrovic, M., Sistilli, G., Horakova, O., & Rossmeisl, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13650 · Cited by 24 · see citing works

The Role of Nutraceuticals in Osteoarthritis Prevention and Treatment: Focus on n‐3 PUFAs

Oppedisano, F., Bulotta, R. M., Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Ilari, S., Serra, M. D. R., Muscoli, C., Gratteri, S., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4878562 · Cited by 24 · see citing works

n-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway

Chen, Y., Fan, Z., Gao, X., Zhou, F., Guo, X., Sinclair, A. J., & Li, D. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109484 · Cited by 23 · see citing works

Endogenous n-3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut–Liver Crosstalk

Jiang, X., Yang, Q., Qu, H., Chen, Y. Q., & Zhu, S. (2023) · Nutrients · doi:10.3390/nu15030586 · Cited by 22 · see citing works

Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice

van den Hoek, A. M., Pieterman, E. J., van der Hoorn, J. W., Iruarrizaga‐Lejarreta, M., Alonso, C., Verschuren, L., Skjæret, T., Princen, H. M. G., & Fraser, D. A. (2019) · Hepatology Communications · doi:10.1002/hep4.1453 · Cited by 22 · see citing works

Improvement in serum lipids and liver morphology after supplementation of the diet with fish oil is more evident under regular feeding conditions than under high-fat or mixed diets in rats

Godea, S., Ciubotariu, D., Danciu, M., Lupușoru, R. V., Ghiciuc, C. M., Cernescu, I. T., Gheţu, N., Lupei, M., & Lupușoru, C. E. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01339-y · Cited by 21 · see citing works

Tetrahydrocurcumin protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis

Gao, F., Chen, M., Yu, J., Xu, L., Yu, L., Jiang, H., & Gu, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104957 · Cited by 20 · see citing works

Plasma phospholipid arachidonic acid in relation to non-alcoholic fatty liver disease: Mendelian randomization study

Chen, J., Ruan, X., Sun, Y., Li, X., Yuan, S., & Larsson, S. C. (2022) · Nutrition · doi:10.1016/j.nut.2022.111910 · Cited by 20 · see citing works

Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice

Xie, F., Xu, H., Zhang, J., Liu, X.-N., Kou, B., Cai, M., Wu, J., Jin-ling, D., Meng, Q., Wang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974872 · Cited by 20 · see citing works

The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD

Sasson, A., Kristoferson, E., Batista, R. O., McClung, J. A., Abraham, N. G., & Peterson, S. J. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108679 · Cited by 19 · see citing works

Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis in mice

Gong, M., Lu, H., Li, L., Feng, M., & Zou, Z. (2023) · Food & Function · doi:10.1039/d2fo03054c · Cited by 19 · see citing works

Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis

Omaña-Guzmán, I., Rosas-Diaz, M., Martínez-López, Y. E., Perez-Navarro, L. M., Diaz-Badillo, A., Alanis, A., Bustamante, A., Castillo-Ruiz, O., del Toro-Cisneros, N., Esquivel-Hernandez, D. A., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03744-x · Cited by 18 · see citing works

Dietary fat intake and liver cancer incidence: A population‐based cohort study in Chinese men

Ji, X., Wang, J., Shen, Q., Li, Z., Jiang, Y., Liu, D., Tan, Y., Li, H., & Xiang, Y. (2021) · International Journal of Cancer · doi:10.1002/ijc.33507 · Cited by 18 · see citing works

Biosynthetic deficiency of docosahexaenoic acid causes nonalcoholic fatty liver disease and ferroptosis-mediated hepatocyte injury

Li, X., Liu, C., Zhang, R., Li, Y., Ye, D., Wang, H., He, M., & Sun, Y. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107405 · Cited by 18 · see citing works

The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway

Ramadan, N. M., Elmasry, K., Elsayed, H. R. H., El‐Mesery, A., & Eraky, S. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121145 · Cited by 18 · see citing works

Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions

Pinheiro-Machado, E., Gurgul-Convey, E., & Marzec, M. (2020) · Archives of medical science : AMS · doi:10.5114/aoms.2020.92674 · Cited by 21 · see citing works

Natural compounds proposed for the management of non-alcoholic fatty liver disease

Merenda, T., Juszczak, F., Ferier, E., Duez, P., Patris, S., Declèves, A., & Nachtergael, A. (2024) · Natural Products and Bioprospecting · doi:10.1007/s13659-024-00445-z · Cited by 18 · see citing works

Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?

Serbis, A., Pοlyzos, S. A., Paschou, S. Α., Siomou, E. C., & Kiortsis, D. N. (2024) · Endocrine · doi:10.1007/s12020-024-03783-7 · Cited by 16 · see citing works

Addition of fish oil to atherogenic high fat diet inhibited atherogenesis while olive oil did not, in LDL receptor KO mice

Harari, A., Leikin-Frenkel, A. I., Barshack, I., Sagee, A., Cohen, H., Kamari, Y., Harats, D., Kandel-Kfir, M., & Shaish, A. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.007 · Cited by 16 · see citing works

Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease

Kalveram, L., Schunck, W., Rothe, M., Rudolph, B. D., Loddenkemper, C., Holzhütter, H., Henning, S., Bufler, P., Schulz, M., Meierhofer, D., et al. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102229 · Cited by 16 · see citing works

Relationship Between Fish Oil Use and Incidence of Primary Liver Cancer: Findings From a Population-Based Prospective Cohort Study

Jiang, W., Li, F.-R., Yang, H.-H., Chen, G.-C., & Hua, Y.-F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.771984 · Cited by 16 · see citing works

Lipoatrophy‐Associated Insulin Resistance and Hepatic Steatosis are Attenuated by Intake of Diet Rich in Omega 3 Fatty Acids

Moreira, R. J., Castro, É., Oliveira, T. E., Belchior, T., Peixoto, Á. S., Chaves‐Filho, A. B., Moreno, M. F., Lima, J. D., Yoshinaga, M. Y., Miyamoto, S., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900833 · Cited by 16 · see citing works

Utilizing the underutilized plant resources for development of life style foods: Putting nutrigenomics to use

Mir, R. A., Nazir, M., Sabreena, Naik, S., Mukhtar, S., Ganai, B. A., & Zargar, S. M. (2022) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2021.12.038 · Cited by 15 · see citing works

Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice

Bednarski, T. K., Rahim, M., Hasenour, C. M., Banerjee, D. R., Trenary, I. A., Wasserman, D. H., & Young, J. D. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100558 · Cited by 15 · see citing works

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice

Xue, X., Wang, L., Wu, R., Li, Y., Liu, R., Ma, Z., Jia, K., Zhang, Y., & Li, X. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00953-7 · Cited by 15 · see citing works

Effect of Carotenoids from Phaeodactylum tricornutum on Palmitate-Treated HepG2 Cells

Mayer, C., Côme, M., Blanckaert, V. D., Zittelli, G. C., Faraloni, C., Nazih, H., Ouguerram, K., Mimouni, V., & Chénais, B. (2020) · Molecules · doi:10.3390/molecules25122845 · Cited by 15 · see citing works

Multi‐omic network analysis identified betacellulin as a novel target of omega‐3 fatty acid attenuation of western diet‐induced nonalcoholic steatohepatitis

Padiadpu, J., García‐Jaramillo, M., Newman, N. K., Pederson, J. W., Rodrigues, R. R., Li, Z., Singh, S. P., Monnier, P. M., Trinchieri, G., Brown, K., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202318367 · Cited by 14 · see citing works

Impact of dietary fiber fraction of chia seed supplementation on hepatic steatosis and other metabolic disturbances in a high-fat diet model

Cisternas, C., Farías, C., Valenzuela, R., Bravo, H., Paz, A. V. C., Alejandra, E., & Muñoz, L. A. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106329 · Cited by 14 · see citing works

Effect of supplementation with different fatty acid profile to the dam in early gestation and to the offspring on the finishing diet on offspring growth and hypothalamus mRNA expression in sheep

Oviedo-Ojeda, M. F., Roque-Jimenez, J. A., Whalin, M., Lee-Rangel, H. A., & Relling, A. E. (2021) · Journal of Animal Science · doi:10.1093/jas/skab064 · Cited by 14 · see citing works

SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women

Yang, J., Félix‐Soriano, E., Martínez-Gayo, A., Ibáñez-Santos, J., Sáinź, N., Martínez, J. A., & Moreno-Aliaga, M. J. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01044-9 · Cited by 13 · see citing works

CXCR4 influences PUFA desaturation and oxidative stress injury in experimental prostatitis mice by activating Fads2 via PPARγ

Zhang, Y., Feng, R., Li, H., Wu, W., Ma, W., Chen, X., Chen, J., & Liang, C. Y. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.07.015 · Cited by 12 · see citing works

Intramuscular adipocyte and fatty acid differences between high‐fat and control rabbit groups subject to a restricted diet

Li, Y., Gan, M., Tang, T., Shao, J., Lai, T., Ma, Y., Elzo, M. A., Jia, X., Hu, S., Wang, J., et al. (2021) · Veterinary Medicine and Science · doi:10.1002/vms3.576 · Cited by 11 · see citing works

The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice

Smid, V., Dvořák, K., Stehnová, K., Strnad, H., Rubert, J., Stritesky, J., Staňková, B., Stranska-Zachariasova, M., Hajšlová, J., Brůha, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417226 · Cited by 12 · see citing works

Participation of the nucleus accumbens dopaminergic system in the antidepressant-like actions of a diet rich in omega-3 polyunsaturated fatty acids

Takeuchi, E., Yamada, D., Suzuki, S., Saitoh, A., Itoh, M., Hayashi, T., Yamada, M., Wada, K., & Sekiguchi, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230647 · Cited by 11 · see citing works

Amelioration of high-fat diet (HFD) + CCl4 induced NASH/NAFLD in CF-1 mice by activation of SIRT-1 using cinnamoyl sulfonamide hydroxamate derivatives: in-silico molecular modelling and in-vivo prediction

Sodum, N., Rao, V., Cheruku, S. P., Kumar, G., Sankhe, R., Kishore, A., Kumar, N., & Rao, C. M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03192-5 · Cited by 10 · see citing works

Increased Expression of Hepatic Stearoyl-CoA Desaturase (SCD)-1 and Depletion of Eicosapentaenoic Acid (EPA) Content following Cytotoxic Cancer Therapy Are Reversed by Dietary Fish Oil

Monirujjaman, M., Renani, L. B., Isesele, P., Dunichand‐Hoedl, A. R., & Mazurak, V. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043547 · Cited by 10 · see citing works

Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M

Liu, H., Li, N., Kuang, G., Gong, X., Wang, T., Hu, J., Hu, J., Zhong, M., Guo, J., Xie, Y., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.11.011 · Cited by 9 · see citing works

Mechanisms of Bioactive Lipids to Modulate Master Regulators of Lipid Homeostasis and Inflammation in Metabolic Syndrome

Estefes-Duarte, J. A., Espinosa‐Sánchez, A., Pérez‐Hernández, N., Ortiz, M. I., & Fernández‐Martínez, E. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010340506241014112341 · Cited by 9 · see citing works

The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Yang, Y., Li, S., Xu, Y., Ke, J., & Zhao, D. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s350579 · Cited by 9 · see citing works

Bioactive lipids: Chemistry, biochemistry, and biological properties

Salsinha, A. S., Machado, M., Rodríguez-Alcalá, L. M., Gomes, A., & Pintado, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00014-2 · Cited by 11 · see citing works

Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice

Spooner, M. H., García‐Jaramillo, M., Apperson, K. D., Löhr, C. V., & Jump, D. Β. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292432 · Cited by 9 · see citing works

Supplementation with Silybum marianum Extract, Synbiotics, Omega-3 Fatty Acids, Vitamins, and Minerals: Impact on Biochemical Markers and Fecal Microbiome in Overweight Dogs

Balouei, F., Stefanon, B., Martello, E., Atuahene, D., Sandri, M., & Meineri, G. (2024) · Animals · doi:10.3390/ani14040579 · Cited by 9 · see citing works

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease

Kytikovа, O. Y., Novgorodtseva, T. P., Denisenko, Y., & Kovalevskiy, D. A. (2020) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2020-30-2-15-25 · Cited by 9 · see citing works

Associations of fatty acids composition and estimated desaturase activities in erythrocyte phospholipids with biochemical and clinical indicators of cardiometabolic risk in non-diabetic Serbian women: the role of level of adiposity

Šarac, I., Debeljak-Martačić, J., Takić, M. M., Stevanović, V. B., Milešević, J. P., Zeković, M., Popović, T. B., Jovanović, J., & Kardum, N. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1065578 · Cited by 8 · see citing works

Early transcriptome changes associated with western diet induced NASH in Ldlr−/− mice points to activation of hepatic macrophages and an acute phase response

Padiadpu, J., Spooner, M. H., Li, Z., Newman, N. K., Löhr, C. V., Apperson, K. D., Dzutsev, A., Trinchieri, G., Shulzhenko, N., Morgun, A., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1147602 · Cited by 8 · see citing works

G-Protein-Coupled Receptor 120 Agonist Mitigates Steatotic and Fibrotic Features Triggered in Obese Mice by the Administration of a High-Fat and High-Carbohydrate Diet

Pompili, S., Cappariello, A., Vetuschi, A., & Sferra, R. (2024) · ACS Omega · doi:10.1021/acsomega.4c03507 · Cited by 8 · see citing works

Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study

Marín-Alejandre, B. A., Abete, I., Monreal, J. I., Elorz, M., Benito, A., Herrero, J. I., Navarro-Blasco, Í., Tur, J. A., Bandarra, N. M., Zulet, M. Á., et al. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.08.007 · Cited by 8 · see citing works

Associations Of Delta Fatty Acid Desaturase Gene Polymorphisms With Lipid Metabolism Disorders

Kytikovа, O. Y., Novgorodtseva, T. P., Denisenko, Y., Antonyuk, M. V., & Gvozdenko, T. A. (2021) · Russian Open Medical Journal · doi:10.15275/rusomj.2021.0403 · Cited by 8 · see citing works

You Are What You Eat: A Review on Dietary Interventions for Treating Pediatric Nonalcoholic Fatty Liver Disease

Sandel, P., Ma, L., Wang, H., & Pasman, E. A. (2023) · Nutrients · doi:10.3390/nu15153350 · Cited by 7 · see citing works

The Truth About Fish (Oil) in the Treatment of Dyslipidemia

Pitha, J. V., & Poledne, R. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00904-9 · Cited by 7 · see citing works

Plant and marine N3-PUFA regulation of fatty acid trafficking along the adipose tissue-liver axis varies according to nutritional state

Rajna, A., Brown, L. H., Frangos, S. M., Gonzalez‐Soto, M., Hucik, B., Wang, C., Wright, D. C., & Mutch, D. M. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108940 · Cited by 7 · see citing works

Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica

Lanuza, F., SAPUNAR, J., & Hofmann, E. (2018) · Revista médica de Chile · doi:10.4067/s0034-98872018000800894 · Cited by 7 · see citing works

Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD

Sabinari, I. W., Horakova, O., Čajka, T., Kleinova, V., Wieckowski, M. R., & Rossmeisl, M. (2024) · Physiological Research · doi:10.33549/physiolres.935396 · Cited by 6 · see citing works

Nonlinear relationships of circulating polyunsaturated fatty acids with the complications of liver cirrhosis: A prospective, longitudinal cohort study

Guo, C., Liu, Z., Fan, H. X., Wang, H., Zhang, X., Zhao, S., Li, Y., Wang, T., Dai, L., Huang, J., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.07.027 · Cited by 6 · see citing works

Supplementation with Docosahexaenoic Acid and Vitamin E Improves Hepatic Triglyceride Accumulation Induced by High‐Fat Diet in Mice

Yuan, G., Xu, M., Tan, M., Dong, J., & Chen, X. (2020) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202000224 · Cited by 6 · see citing works

Effects of full-fat black soldier fly larvae and yellow mealworm meals on blood composition and liver health in Atlantic salmon (Salmo salar)

Islam, S. M., Sørensen, M., Siddik, M. A. B., Willora, F. P., Brinchmann, M. F., Spiten, K., Zatti, K., Thompson, K. D., & Vatsos, I. N. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.743142 · Cited by 5 · see citing works

Fishing for Solutions: How Pre‐Conceptional Fish Oil Supplementation in Obese Fathers Reduces Risk of Non‐Alcoholic Fatty Liver Disease in Offspring Mice

Yang, J., Shrestha, A., & Ramalingam, L. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400452 · Cited by 5 · see citing works

EPA plus DHA improves survival related to a decrease of injury after extended liver ischemia in Sprague-Dawley rats

Céspedes, N., Tamayo, A., Rodrí­guez, M. J., & Zúñiga‐Hernández, J. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.09.003 · Cited by 5 · see citing works

Microalgae as source of edible lipids

de Morais, E. G., Schüler, L., Pereira, H., Maia, I. B., Gangadhar, K. N., Costa, J. A. V., de Morais, M. G., Varela, J. C. S., & Barreira, L. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821080-2.00015-0 · Cited by 5 · see citing works

Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use

Spooner, M. H., & Jump, D. Β. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030223 · Cited by 60 · see citing works

The Role of Omega-3 Polyunsaturated Fatty Acids in the Treatment of NAFLD: Evidence Base

Ipatova, M. G., & Bordin, D. S. (2024) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2024-20-30-44-49 · Cited by 1 · see citing works

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease

Minno, M. N. D. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5839 · Cited by 173 · see citing works

Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis

Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569 · see citing works

Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children

Spooner, M. H., & Jump, D. Β. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000539 · Cited by 64 · see citing works